Chemical and Nanotechnology-based Approaches to Build Next-gen Oligonucleotide Therapeutics
Join Aurélie Lacroix, PhD and Leonora Abdullahu, PhD, the 2021/2022 OTS Trainee Reps, as they share about their research [...]
Antisense Oligonucleotide-based Therapies for Inherited Retinal Diseases: From Mutation to Clinical Trial
Speaker: Alex Garanto, PhD Date: March 10, 2022 Time: 11-12 EST Description: The eye is at the forefront of [...]
Meet Your 2022 OTS Trainee Reps
Speaker: Chantal Ferguson, MD, PhD Candidate and Hassan Fakih, PhD Date: February 24, 2022 Time: 11-12 EST Description: The [...]